Treatment Recommendations for Psychedelic-assisted Therapy
Swiss Archives of Neurology Psychiatry and Psychotherapy May 18, 2024 DOI: 10.4414/sanp.2024.1488043038 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Psychotherapist |
| Citations | 17 |
| Key findings | Switzerland established the Swiss Interest Group for Psychedelic-assisted Therapy in 2023 and created a first draft of S1 treatment guidelines for psychedelic-assisted therapy. |
Abstract
Switzerland's early contributions to the 'psychedelic renaissance', the revival of psychedelic science starting in the early 21st century, might be particularly noteworthy given the growing global interest in using psychedelics for research and therapy.In 2023, the Swiss Interest Group for Psychedelic-assisted Therapy was established to provide a clear and widely accepted framework for work related to psychedelic-assisted therapy.Members of this group created a first draft of treatment recommendations (S1 guidelines).These recommendations will be continuously updated to incorporate new findings in research and therapy.
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 18
- Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program Neuroscience Applied 2025
- Further education in psychedelic-assisted therapy - experiences from Switzerland. BMC Medical Education March 5, 2025
- Psychothérapie assistée par psychédéliques (PAP) : le modèle genevois Annales Médico-psychologiques revue psychiatrique July 10, 2024
- Reframing psychedelic regulation: Tools, not treatments Drug Science, Policy and Law June 16, 2025
- The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy. Current Topics in Behavioral Neurosciences November 22, 2025
and 13 more in the library
Cites 9
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases The Journal of Nervous and Mental Disease March 4, 2014
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Journal of Psychopharmacology November 11, 2014
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Journal of Psychopharmacology October 31, 2012
- Gender differences in the subjective effects of MDMA Psychopharmacology March 5, 2001
- The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval Neuropsychopharmacology February 14, 2007
and 4 more in the library